587 related articles for article (PubMed ID: 8906012)
21. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
22. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
[TBL] [Abstract][Full Text] [Related]
23. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
24. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
Luschin-Ebengreuth G; Petru E; Pickel H
Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():125-6. PubMed ID: 1337488
[No Abstract] [Full Text] [Related]
25. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
26. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
[TBL] [Abstract][Full Text] [Related]
27. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
28. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
29. Choriocarcinoma following ovarian hydatidiform mole: a case report.
Joneborg U; Papadogiannakis N; Lindell G; Marions L
J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
[TBL] [Abstract][Full Text] [Related]
30. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
31. Inter- and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia.
Messerli ML; Parmley T; Woodruff JD; Lilienfeld AM; Bevilacqua L; Rosenshein NB
Obstet Gynecol; 1987 Apr; 69(4):622-6. PubMed ID: 3029643
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical staining properties of PCNA, Ki-67, p53, beta-hCG and HPL in trophoblastic disease.
Ozbilim G; Karaburun SP; Zorlu G; Kaya R; Erdoğan G; Karaveli S
Eur J Gynaecol Oncol; 2000; 21(2):200-4. PubMed ID: 10843487
[TBL] [Abstract][Full Text] [Related]
33. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
Huang SC; Hsieh CY; Ouyang PC
J Formos Med Assoc; 1991 Jan; 90(1):53-8. PubMed ID: 1679110
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
35. Macrophage colony-stimulating factor induces the growth and differentiation of normal pregnancy human cytotrophoblast cells and hydatidiform moles but does not induce the growth and differentiation of choriocarcinoma cells.
Saito S; Ibaraki T; Enomoto M; Ichijo M; Motoyoshi K
Jpn J Cancer Res; 1994 Mar; 85(3):245-52. PubMed ID: 8188522
[TBL] [Abstract][Full Text] [Related]
36. Linkage of human chorionic gonadotrophin and placental lactogen biosynthesis to trophoblast differentiation and tumorigenesis.
Hoshina M; Boothby M; Hussa R; Pattillo R; Camel HM; Boime I
Placenta; 1985; 6(2):163-72. PubMed ID: 2991878
[TBL] [Abstract][Full Text] [Related]
37. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
Mundangepfupfu T; Waseem M
J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
[TBL] [Abstract][Full Text] [Related]
38. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
Lurain JR
Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
40. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]